For research use only. Not for therapeutic Use.
Ruzinurad(Cat No.:I035824)is a selective URAT1 (urate transporter 1) inhibitor developed for the treatment of hyperuricemia and gout. By blocking URAT1 in the renal proximal tubules, ruzinurad effectively reduces serum uric acid levels by enhancing its urinary excretion. It offers a novel mechanism for managing chronic gout, especially in patients with inadequate response or intolerance to xanthine oxidase inhibitors. Ruzinurad’s favorable pharmacokinetic profile and renal selectivity support its potential as a safe and efficacious uricosuric agent in long-term urate-lowering therapy.
CAS Number | 1638327-48-6 |
Synonyms | 1-(6-bromoquinolin-4-yl)sulfanylcyclobutane-1-carboxylic acid |
Molecular Formula | C14H12BrNO2S |
Purity | ≥95% |
IUPAC Name | 1-(6-bromoquinolin-4-yl)sulfanylcyclobutane-1-carboxylic acid |
InChI | InChI=1S/C14H12BrNO2S/c15-9-2-3-11-10(8-9)12(4-7-16-11)19-14(13(17)18)5-1-6-14/h2-4,7-8H,1,5-6H2,(H,17,18) |
InChIKey | QGBWIYLNOBYNDL-UHFFFAOYSA-N |
SMILES | C1CC(C1)(C(=O)O)SC2=C3C=C(C=CC3=NC=C2)Br |
Chemistry Calculators | Dilution Calculator In vivo Formulation Calculator Molarity Calculator Molecular Weight Calculator Reconstitution Calculator |